Brain Awareness Week Partner Interview: NW Noggin

This is the third in a series of Brain Awareness Week (BAW) partner interviews, in which partners share their BAW experiences and tips for planning successful events. Bill Griesar, Ph.D., is a psychology and neuroscience professor at Portland State University (PSU), Washington State University (WSU) Vancouver, and Oregon Health & Science University (OHSU), and is the neuroscience outreach coordinator for NW Noggin (Neuroscience Outreach Group Growing In Networks). Griesar works together with Jeff Leake, who also teaches at PSU and WSUV, and is NW Noggin’s art education coordinator.   

sfnsandiego

Griesar (left) and Leake (right) at the 2016 Society for Neuroscience conference in San Diego

NW Noggin was conceptualized in 2012 for a group of middle school students at a public school in Portland, Oregon. With support from organizations like the Immigrant & Refugee Community Organization (IRCO) and the Association for Psychological Science, your group has now expanded to a nationwide focus. Can you talk about how you were able to expand so rapidly in such a short amount of time? 

BG: Through the tireless enthusiasm of our graduate and undergraduate volunteers, who quickly discovered how much they enjoy sharing what they’re learning about the brain with young people and the public. It’s also the multi-disciplinary nature of the outreach, with young scientists and artists working together and discovering similarities in their process: the creative experimentation, the structure-function relationships, the fun, often the messiness, and certainly the need to communicate!

Continue reading

Neuroethics and the BRAIN Initiative

brain-initiative-neuroethicsNeuroscience “is the science that is going to change the way people live, die, and think about themselves,” said Stanford Law professor Hank Greely during the third annual BRAIN Initiative investigators meeting, held in Bethesda, Md., last week. Research into the workings of the brain raises many ethical questions, some common to bioethics and others—such as questions of agency, consciousness, and identity—that are unique to the brain and central nervous system.

Neuroethics has been mentioned from the first public announcement of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative in 2013; a BRAINI workgroup is devoted to the topic. It is one of nine BRAIN Initiative priority funding areas for the coming fiscal year (grant info). At this meeting, a regular session was devoted to the topic, featuring five of the members of the workgroup, and it also came up in other sessions.

Continue reading

Progress in BRAIN Initiative Research

brain_obama_robotics

President Barack Obama fist-bumps the robotic arm of Nathan Copeland during a tour at the White House Frontiers Conference at the University of Pittsburgh, Oct. 13, 2016. (Official White House Photo by Pete Souza)

In the less than three years since the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative was announced, researchers have made measurable progress towards creating new tools and sharpening existing ones to study the brain. Though its goals are long-term, in a few cases this progress already has shown promise in helping people.

These tools “allow us to do things that, in the past, were unimaginable,” said Nora Volkow of the National Institute of Drug Abuse during the third annual BRAIN Initiative investigators meeting, held in Bethesda, Md., this week. For example, imaging tech such as fMRI and PET have enabled us to make maps of brain activity and create a brain atlas of the concentration of serotonin transporters and receptors. But to reach goals as ambitious as characterizing the many types of neurons and other cells in the brain—or even to get a good count of how many types there are—we need to improve both the speed and the resolution of our tools.

Continue reading

The Ethics of Genetic Technologies

On Thursday, Dana Alliance member Steven E. Hyman helped the International Neuroethics Society (INS) kick off its annual meeting in San Diego. INS President and fellow Dana Alliance member Judy Illes welcomed attendees and introduced Hyman, who opened the program with his presentation titled, “Emerging Genetics of Human Cognition and Behavior: New Challenges for Ethics and Policy.”

ins-hyman-talk-aw-450

Steven Hyman, M.D.

“Scientists always knew that genetics would help us,” he began, “but the trouble was that it is fiendishly complex, and the technology was, at the time, unavailable…I truly didn’t expect to live long enough to see [it] develop.”

With the commencement of the Human Genome Project, technologies were suddenly available that allowed scientists to yield information crucial to the sequencing and mapping of all genes. In that same decade, he commented, the BRAIN Initiative and stem cell technologies were also developed, adding another feat to neuroscience research. With this, Hyman said, it suddenly became possible to fundamentally try to understand schizophrenia, bipolar disorder, and other nervous system diseases, such as epilepsy, Parkinson’s disease, and so on.

Continue reading

From the Archives: Funding Scientific Research

Leon Cooper in 2007. Photo by Kenneth C. Zirkel

Leon Cooper in 2007. Photo by Kenneth C. Zirkel

More than 16 years ago, Cerebrum published an essay by Leon Cooper, Nobel prize-winning physicist and a member of the executive committee of the Dana Alliance for Brain Initiatives, on the monetary state of the field then, called “Scientific Research: Who Benefits? Who Pays?” Has anything changed?

In 1998, the annual direct and indirect costs of brain-related illnesses in the U.S. was estimated at $600 billion, writes Cooper. The figure now is $760 billion; worldwide, the WHO has estimated costs at $3 trillion and increasing. Continue reading

%d bloggers like this: